Sign in
Taking peopleNo phase

Multicenter iTBS Neuromodulation for PTSD Treatment

Key facts

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Where
China5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
140 people, planned
Started
30 Oct 2024
Expected to end
Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • sham stimulation
  • intermittent theta-burst stimulation (iTBS)
Record updated
3 August 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Aged between 18 to 65 years old
  • Right handedness
  • Have a diagnosis of PTSD meeting DSM-5 criteria
  • CAPS-5 score>35
  • Under stable medication for at least four weeks
  • Capable of independently reading and understanding study materials and providing informed consent

Who cannot take part

  • Implanted device (deep brain stimulation) or metal in the brain; a pacemaker, extensive dental work, or any magnetic metal implants and upper body tattoos if choose to do fMRI
  • Previous experience of rTMS
  • Current (or past if appropriate) significant neurological or medical disorder, or lifetime history of 1) seizure disorder; 2) primary or secondary CNS tumors; 3) stroke; or 4) cerebral aneurysm
  • Primary psychotic disorder, bipolar I disorder, major depressive disorder, or personality disorders
  • Lifetime history of attempted suicide or HAMD-17 suicide item (item 3) ≥ 3 points
  • Pregnancy/lactation, or planning to become pregnant during the study
  • Current under psychological or other physical treatments

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The proposed study aims to evaluate the efficacy of intermittent theta-burst transcranial magnetic stimulation (iTBS) targeting primary motor cortex (M1) as adjunct treatment for PTSD patients. The primary outcome measure includes changes in PTSD symptom severity, with secondary outcome measures focusing on negative moods improvements, quality of life and social/occupation functioning and functional connectivity of the brain.

The 2 groups in the trial

  • Sham stimulationSham treatment, for comparison

    A sham coil with exactly the same appearance of active coil is used to compare with active coil. Stimulation dose and frequency is the same as active stimulation.

  • Active stimulationExisting treatment, for comparison

    An active coil is used to deliver iTBS. The stimulation dose is 20 sessions (1800 pulses per session; 2 sessions a day, at least 1 hour apart) over the course of 2 weeks (10 days to 14 days, allow at most three breaks and only once of the longest interval of 2 days).

    Treatment: intermittent theta-burst stimulation (iTBS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Clinical Study on Transcranial Magnetic Stimulation of the Primary Motor Cortex for PTSD Treatment
Criteria questions
Built from NCT06434766, who can take part
Record updated
3 August 2026